Director, Human Resources Technology – Workday Architect

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 7, 2026

Salary

$211K-$264K From the posting source checked Jun 20, 2026

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$81,650 U.S. median for this role

Projected growth (BLS Employment Projections)

+6.9% - Faster than average

191% above the BLS role benchmark for human resources aggregate.

Matched to SOC 13-1071 - Human Resources aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Hr From the posting source checked Jun 20, 2026

Seniority

Director Plus From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, Human Resources Technology – Workday Architect Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a rapidly growing biotech company, we are scaling our enterprise systems to support a dynamic workforce, evolving regulatory requirements, and complex financial operations. We are seeking a Workday Architect person to lead the design, development, and optimization of our Workday platform. - Oversee the end-to-end architecture, governance, and optimization of the Workday ecosystem including HCM, Learning, Talent, Peakon, Sana, and Advanced Compensation etc. - Provide architectural oversight and governance for external implementation partners, AMS providers, and integration vendors to ensure alignment with enterprise standards and strategic objectives. - Drive enterprise architecture decisions across the HR technology ecosystem by partnering with IT Enterprise Architecture, IT Security, and Finance teams to ensure scalable, compliant, and business-aligned solutions across Workday and interconnected enterprise platforms. - Lead adoption and governance of AI-enabled HR technologies, intelligent automation, and digital workflow capabilities across the Workday

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.